European Commission Approves Endoceutics’ Drug IntrarosaTM for the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Quebec, Canada, January 15, 2018 –(PR.com)– The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa – Prasterone," a medicinal product for human use. IntrarosaTM is intended for the treatment of

Read More

cliexa® Partners with Preventative Technology Solutions on Risk Assessment Solutions; New Product Will Help Physicians Address Behavioral Health Risks in Adolescents

Denver, CO, December 19, 2017 –(PR.com)– cliexa, Inc., developer of a mobile platform for chronic disease management, announces today a collaboration with Preventative Technology Solutions, Inc., (PTSI), provider of medical assessment applications and mHealth prevention services for adolescents and young adults. cliexa has licensed PTSI assessment technology to launch cliexa-Options, a suite of behavioral health

Read More

Blue Diesel Data Science Introduces Pharmaceutical Insight Platform Reducing Research Time from Weeks to Minutes

Minneapolis, MN, December 10, 2017 –(PR.com)– Blue Diesel Data Science LLC., a privately held data science company specializing in analytics and business intelligence, announced the beta launch of its pharmaceutical insight platform. VisionaryRX™ provides a deep and comprehensive view into the drug industry. This launch follows an aggressive schedule where releases were on a weekly

Read More

RowAnalytics, Martinos Center & Envision Genomics Create GIRO Health, a New Flagship Open Initiative in Precision Medicine

Cambridge, MA, December 07, 2017 –(PR.com)– RowAnalytics Ltd., the Martinos Center for Biomedical Imaging (Martinos Center) and Envision Genomics Inc. today announced that they are combining their world leading technologies and expertise with IBM Power servers, to create a new, open initiative in precision medicine, GIRO Health. This initiative will accelerate understanding of the biology

Read More

Advance Reviews, Awards for Uniquely Normal: Tapping the Reservoir of Normalcy to Treat Autism Suggest a “Game-Changer” Book

Arlington, TX, December 04, 2017 –(PR.com)– Advance praise for Robert J. Bernstein’s Uniquely Normal book involve terms like “ground-breaking,”1 “extraordinary,”2 “compelling,”3 “revolutionary”4 and an “alternative to Applied Behavior Analysis (ABA).”5 The book also just won the 2017 Best Book Awards’ “Winner” in the "Health: Psychology/Mental Health" category as well as the Best Book silver award

Read More

RowAnalytics Cements Its North American Presence with a New Office in Boston – to Introduce a Radically Different Approach to Precision Medicine

Cambridge, MA, November 30, 2017 –(PR.com)– RowAnalytics today announced that it has established its presence in North America with an office in Cambridge, MA to further collaborative research in precision medicine with the world’s leading academic, clinical and biotechnology organizations. Located in the heart of Kendall Square, which offers an inspirational rich history in biotech

Read More

Perthera and ZERO Announce the Decode Your Prostate Cancer Program

McLean, VA, November 28, 2017 –(PR.com)– Perthera, Inc., the leading Therapeutics Intelligence Company™, has announced its partnership with ZERO, the leading nonprofit prostate cancer advocacy group in the USA, to form and launch the nationwide Decode Your Prostate Cancer program aimed to provide each prostate cancer patient with therapeutic treatment options precisely matched to their

Read More

Stool Bank in Asia Welcomes New Scientist

New York, NY, November 16, 2017 –(PR.com)– The Asia Microbiota Bank Welcomes New Scientific Team Member The Asia Microbiota Bank (AMB), headquartered in Hong Kong, is pleased to announce they have been joined by a new scientific team member, Subramanya Rao, PhD. As an expert microbiologist and bioinformatician, Dr. Rao will lead the laboratory production

Read More

Cellenkos Inc. Enters Regulatory T-Cell Platform Research Collaboration with MD Anderson

Houston, TX, November 15, 2017 –(PR.com)– Cellenkos Inc. has announced a multi-year collaboration with The University of Texas MD Anderson Cancer Center focused on development of cord blood regulatory T cell (CB TREG) therapeutics for treatment of autoimmune disease and inflammatory disorders. As part of this collaboration, Cellenkos Inc. will fund up to 10,000,000 USD

Read More

Berry Brunk Promoted to Chief Executive Officer, Stratus Interoperable, Inc., Effective January 1, 2018

Nanuet, NY, November 15, 2017 –(PR.com)– Healthcare technology innovator Stratus Interoperable, Inc. (SI), announced the promotion of Berry Brunk, to Chief Executive Officer effective January 1, 2018. The announcement was made by Fred Zolla, CEO and Chairman of SI. “Mr. Brunk’s ability to bring immediate and meaningful strategic change and attract world class talent into

Read More